Cabotegravir for Prevention of HIV-1 in Women: Results From HPTN 084, a Phase III, Randomised Controlled Trial
暂无分享，去创建一个
S. Delany-Moretlwe | J. Hughes | M. Moorhouse | N. Mgodi | C. Nakabiito | C. Hendrix | M. Marzinke | E. Tolley | S. Hosek | J. Mpendo | M. Hosseinipour | S. Eshleman | W. Spreen | S. Rose | L. Emel | G. Nair | B. Hanscom | E. Piwowar-Manning | A. Rinehart | H. Nuwagaba-Biribonwoha | J. Makhema | N. Kayange | Kevin Bokoch | J. Rooney | Pamela G Mukwekwerere | N. Sista | F. Conradie | P. Bock | R. Panchia | A. Adeyeye | E. Spooner | P. Richardson | A. Asmelash | R. Berhanu | B. Siziba | Y. Agyei | J. Farrior | Katherine Shin | N. Singh | Rhonda White | Portia Hunidzarira | D. Kalonji | Peter L. Anderson | M. Cohen | P. Mandima | Carrie-Anne Mathew | P. N. Ntege | Stephanie Beigel-Orme | S. Ouma | Kimberly Smith | Rhonda R White